CClinicalTrials.gg
Sign In
CompletedNCT00411294Updated Dec 13, 2006

Ergocalciferol in Chronic Kidney Disease

An observational study in Chronic Kidney Disease, sponsored by Saint Louis VA Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2006-12-13.

Sponsored by Saint Louis VA Medical Center · Observational

Study type
Observational
Model
Defined population
Time perspective
Retrospective
Ages
18 Years to 80 Years
Sex
All
01

Study summary

To examine the effect of ergocalciferol treatment on 25-hydroxyvitamin D and PTH levels in patients with CKD stage 3 and 4

02

Conditions studied

  • Chronic Kidney Disease

Keywords

  • ergocalciferol
  • chronic kidney disease
  • secondary hyperparathyroidism
  • vitamin D deficiency
03

In context

Kidney Diseases

3,840 studies on the registry are indexed under Kidney Diseases; 500 are open to participants now.

Browse Kidney Diseases studies →

Lead sponsor

Saint Louis VA Medical Center is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient with CKD stage 3 or 4 whose 25-hydroxyvitamin D levels are below 30 ng/ml and plasma intact PTH levels >70 pg/ml.

Exclusion criteria

Exclusion Criteria:

  • Patients who are on any form of active vitamin treatment
05

Study design

Observational model
Defined population
Time perspective
Retrospective
06

Study locations

1 site
  • Saint Louis VA Medical Center
    Saint Louis, Missouri 63104, United States
07

References and documents

Publications

  • Al-Aly Z, Qazi RA, Gonzalez EA, Zeringue A, Martin KJ. Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis. 2007 Jul;50(1):59-68. doi: 10.1053/j.ajkd.2007.04.010. PubMed 17591525 ↗
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 13, 2006, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00411294
Lead sponsor
Saint Louis VA Medical Center
First posted
Dec 13, 2006
Last update
Dec 13, 2006

Study contacts

Ziyad Al-Aly, M.D.
principal investigator · VAMC-Saint Louis
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2006. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Kidney Diseases→

Other studies from this sponsor

Saint Louis VA Medical Center

Start the discussion